MATINAS BIOPHARMA HOLDINGS, INC. Revenues
MATINAS BIOPHARMA HOLDINGS, INC. (MTNB) reported Revenues of $89.81 thousand for the 3-month period ending 2019-06-30, per its 10-Q filed 2019-08-13.
Discontinued › Income Statement
us-gaap:Revenues · last filed 2019-08-13
- MATINAS BIOPHARMA HOLDINGS, INC. revenues for the quarter ending 2019-06-30 was $89.81K, a 0.00% decline year-over-year.
- MATINAS BIOPHARMA HOLDINGS, INC. revenues for the quarter ending 2018-12-31 was $0.00, a 100.00% decline year-over-year.
- MATINAS BIOPHARMA HOLDINGS, INC. revenues for the quarter ending 2018-09-30 was $0.00, a 100.00% decline year-over-year.
- MATINAS BIOPHARMA HOLDINGS, INC. revenues for the quarter ending 2018-06-30 was $89.81K, a 100.00% increase year-over-year.
- MATINAS BIOPHARMA HOLDINGS, INC. revenues for fiscal 2018 was $119.75K, a 20.00% decline from fiscal 2017.
- MATINAS BIOPHARMA HOLDINGS, INC. revenues for fiscal 2017 was $149.69K.
- MATINAS BIOPHARMA HOLDINGS, INC. revenues for fiscal 2016 was $0.00, a 100.00% decline from fiscal 2015.
- MATINAS BIOPHARMA HOLDINGS, INC. revenues for fiscal 2015 was $194.49K.
| Period end | Revenues 3 month | Revenues 6 month | Revenues 9 month | Revenues 12 month |
|---|---|---|---|---|
| 2019-06-30 | $89.81K 10-Q · filed 2019-08-13 | $89.81K 10-Q · filed 2019-08-13 | ||
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-04-01 | $0.00 derived: sum of 2 quarters · filed 2019-04-01 | $89.81K derived: sum of 3 quarters · filed 2019-08-13 | $119.75K 10-K · filed 2019-04-01 |
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-09 | $89.81K derived: sum of 2 quarters · filed 2019-08-13 | $119.75K 10-Q · filed 2018-11-09 | $164.66K derived: sum of 4 quarters · filed 2019-08-13 |
| 2018-06-30 | $89.81K 10-Q · filed 2019-08-13 | $119.75K 10-Q · filed 2019-08-13 | $164.66K derived: sum of 3 quarters · filed 2019-08-13 | $209.56K derived: sum of 4 quarters · filed 2019-08-13 |
| 2018-03-31 | $29.94K 10-Q · filed 2019-05-13 | $74.84K derived: sum of 2 quarters · filed 2019-05-13 | $119.75K derived: sum of 3 quarters · filed 2019-05-13 | $164.66K derived: sum of 4 quarters · filed 2019-05-13 |
| 2017-12-31 | $44.91K derived: 10-K 12 month − 10-Q 9 month · filed 2019-04-01 | $89.81K derived: sum of 2 quarters · filed 2019-04-01 | $134.72K derived: sum of 3 quarters · filed 2019-04-01 | $149.69K 10-K · filed 2019-04-01 |
| 2017-09-30 | $44.91K 10-Q · filed 2018-11-09 | $89.81K derived: sum of 2 quarters · filed 2018-11-09 | $104.78K 10-Q · filed 2018-11-09 | $104.78K derived: sum of 4 quarters · filed 2018-11-09 |
| 2017-06-30 | $44.91K 10-Q · filed 2018-08-09 | $59.88K 10-Q · filed 2018-08-09 | $59.88K derived: sum of 3 quarters · filed 2018-08-09 | $59.88K derived: sum of 4 quarters · filed 2018-08-09 |
| 2017-03-31 | $14.97K 10-Q · filed 2018-05-09 | $14.97K derived: sum of 2 quarters · filed 2018-05-09 | $14.97K derived: sum of 3 quarters · filed 2018-05-09 | $14.97K derived: sum of 4 quarters · filed 2018-05-09 |
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-31 | $0.00 derived: sum of 2 quarters · filed 2017-03-31 | $0.00 derived: sum of 3 quarters · filed 2017-08-08 | $0.00 10-K · filed 2017-03-31 |
| 2016-09-30 | $0.00 10-Q · filed 2016-11-14 | $0.00 derived: sum of 2 quarters · filed 2017-08-08 | $0.00 10-Q · filed 2016-11-14 | $0.00 derived: sum of 4 quarters · filed 2018-03-16 |
| 2016-06-30 | $0.00 10-Q · filed 2017-08-08 | $0.00 10-Q · filed 2017-08-08 | $0.00 derived: sum of 3 quarters · filed 2018-03-16 | $59.86K derived: sum of 4 quarters · filed 2018-03-16 |
| 2016-03-31 | $0.00 10-Q · filed 2017-05-15 | $0.00 derived: sum of 2 quarters · filed 2018-03-16 | $59.86K derived: sum of 3 quarters · filed 2018-03-16 | $136.86K derived: sum of 4 quarters · filed 2018-03-16 |
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-16 | $59.86K derived: sum of 2 quarters · filed 2018-03-16 | $136.86K derived: sum of 3 quarters · filed 2018-03-16 | $194.49K 10-K · filed 2018-03-16 |
| 2015-09-30 | $59.86K 10-Q · filed 2016-11-14 | $136.86K derived: sum of 2 quarters · filed 2016-11-14 | $194.49K 10-Q · filed 2016-11-14 | $194.49K derived: sum of 4 quarters · filed 2016-11-14 |
| 2015-06-30 | $77.00K 10-Q · filed 2016-08-15 | $134.64K 10-Q · filed 2016-08-15 | $134.64K derived: sum of 3 quarters · filed 2016-08-15 | $134.64K derived: sum of 4 quarters · filed 2016-08-15 |
| 2015-03-31 | $57.64K 10-Q · filed 2016-05-13 | $57.64K derived: sum of 2 quarters · filed 2016-05-13 | $57.64K derived: sum of 3 quarters · filed 2016-05-13 | |
| 2014-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-30 | $0.00 derived: sum of 2 quarters · filed 2016-03-30 | $0.00 10-K · filed 2016-03-30 | |
| 2014-09-30 | $0.00 10-Q · filed 2015-11-10 | $0.00 10-Q · filed 2015-11-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| Nexentis Technologies Inc. (NXTS) | $0.002B |